Quick Answer
Evommune, Inc. reported Total Assets of $224.95 million for fiscal year 2025.
Evommune, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $224.95M | +195.8% |
| 2024 | $76.06M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $84.54M | — | +11.2% |
| December 31, 2024 | $76.06M | — | — |
- Evommune, Inc. showed an increase of +195.8% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Evommune, Inc.’s total assets has grown by 195.8% (from $76.06 million to $224.95 million).
- The most recent figure is from Evommune, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: